FARESTON Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Fareston, and when can generic versions of Fareston launch?
Fareston is a drug marketed by Kyowa Kirin and is included in one NDA.
The generic ingredient in FARESTON is toremifene citrate. There are five drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the toremifene citrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Fareston
A generic version of FARESTON was approved as toremifene citrate by RISING on December 4th, 2018.
Summary for FARESTON
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 70 |
Clinical Trials: | 9 |
Patent Applications: | 8,470 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for FARESTON |
What excipients (inactive ingredients) are in FARESTON? | FARESTON excipients list |
DailyMed Link: | FARESTON at DailyMed |
Recent Clinical Trials for FARESTON
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Fred Hutchinson Cancer Research Center | Phase 4 |
National Cancer Institute (NCI) | Phase 4 |
The Third Affiliated Hospital of Kunming Medical College. | Phase 3 |
Pharmacology for FARESTON
Drug Class | Estrogen Agonist/Antagonist |
Mechanism of Action | Selective Estrogen Receptor Modulators |
Anatomical Therapeutic Chemical (ATC) Classes for FARESTON
US Patents and Regulatory Information for FARESTON
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Kyowa Kirin | FARESTON | toremifene citrate | TABLET;ORAL | 020497-001 | May 29, 1997 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for FARESTON
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Kyowa Kirin | FARESTON | toremifene citrate | TABLET;ORAL | 020497-001 | May 29, 1997 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for FARESTON
See the table below for patents covering FARESTON around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Denmark | 170927 | ⤷ Try a Trial | |
Germany | 3366021 | ⤷ Try a Trial | |
Australia | 556608 | ⤷ Try a Trial | |
Hungary | T34944 | ⤷ Try a Trial | |
U.S.S.R. | 1508955 | CПOCOБ ПOЛУЧEHИЯ AЛKEHOBЫX ПPOИЗBOДHЫX ИЛИ ИX COЛEЙ (METHOD OF PRODUCING ALKENE DERIVATIVES OR THEIR SALTS) | ⤷ Try a Trial |
Denmark | 236683 | ⤷ Try a Trial | |
Denmark | 165785 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for FARESTON
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0095875 | SPC/GB96/029 | United Kingdom | ⤷ Try a Trial | |
0095875 | 96C0029 | Belgium | ⤷ Try a Trial | PRODUCT NAME: TOREMIFENE; REGISTRATION NO/DATE: EU/1/96/004/001 19960215 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |